CRL
Charles River Laboratories International, Inc.
Stock
$290.19+3.36 (+1.17%)Close Oct 2, 2026
- Operating income, 2025
- $25M
- YoY, 2025
- −88.9%
- 5-year CAGR
- −43.4%
- 10-year CAGR
- −19.0%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $25M | −88.9% |
| 2024 | $227M | −63.2% |
| 2023 | $617M | −5.2% |
| 2022 | $651M | +10.4% |
| 2021 | $590M | +36.3% |
| 2020 | $433M | +23.2% |
| 2019 | $351M | +6.0% |
| 2018 | $331M | +15.0% |
| 2017 | $288M | +21.4% |
| 2016 | $238M | +15.1% |
| 2015 | $206M | +16.2% |
| 2014 | $178M | +17.4% |
| 2013 | $151M | −8.7% |
| 2012 | $166M | −4.9% |
| 2011 | $174M | — |
| 2010 | −$299M | — |
| 2009 | $170M | — |
| 2008 | −$452M | — |